XML 45 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Payables and Accruals [Abstract]    
Bonus $ 454,494 $ 2,538,340
Deferred revenue-R&D for TPOXX® intravenous formulation 1,255,318 1,255,318
Professional fees 405,096 381,980
Vacation 361,755 328,588
Other (primarily R&D vendors and CMOs) 1,109,532 977,353
Accrued expenses and other current liabilities $ 3,586,195 $ 5,481,579